Phytopreparations in complex treatment of patients with benign prostatic hyperplasia and erectile dysfunction-Reference-Cited by-同舟云学术

Phytopreparations in complex treatment of patients with benign prostatic hyperplasia and erectile dysfunction

Published:2018-12-23 Issue:4 Volume:19 Page:46-53
ISSN:2412-8902
Container-title:Andrology and Genital Surgery
language:
Short-container-title:Androl. genit. hir.

Author:

Bat’ko A. B.¹^ORCID

Affiliation:

1. Multi-specialty clinic “Family doctor”

Abstract

The study objectiveis to evaluate clinical effectiveness of a phytopharmaceutical Vialissil® for treatment of patients with benign prostatic hyperplasia (BPH) and erectile dysfunction.Materials and methods. At the multi-specialty clinic “Family Doctor” (Saint Petersburg) 34 patients aged from 55 to 67 years (mean age 59.6 + 0.7 years) with BPH and concomitant erectile dysfunction without the need for surgical intervention were examined. All patients received previously prescribed symptomatic therapy for BPH and erectile dysfunction (a-adrenoblockers and phosphodiesterase type 5 inhibitors on demand). The treatment group included 18 patients who additionally received Vialissil® as capsules once a day for 30 days. The remaining 16 patients were the control group.Results.After treatment, intensity of general symptoms decreased more in the treatment group than in the control group (by 10 and 4 points, respectively). After the course of therapy, erectile function improved in both groups but only in the treatment group these dynamics were statistically significant. An increase in testosterone level was statistically significant only after combination therapy with Vialissil® (by 16.5 %), and blood level of biologically accessible (active) testosterone increased twofold.Conclusion.Combination therapy for BPH and erectile dysfunction including administration of the Vialissil® phytopharmaceutical more effectively decreases disease intensity compared to standard therapy.

Publisher

Publishing House ABV Press

Subject

Urology,Reproductive Medicine,Surgery

Reference37 articles.

1. Tuzikov I.A., Kalinchenko S.Yu., Vorslov L.O. et al. Asymptomatic benign prostatic hyperplasia: the three faces of the same problem. Russky meditsinsky zhurnal = Russian Medical Journal 2013;21(34):1768—72. (In Russ.).

2. Kalinina S.N., Burlaka O.O., Aleksandrov M.S., Vydryn P.S. Diagnosis and treatment of lower urinary tract symptoms and erectile dysfunction in patients with benign prostate hyperplasia. Urologicheskie vedomosti = Urological Statements 2018;8(1):26—33. (In Russ.). DOI: 10.17816/uroved8126-33.

3. Petrichko M.I., Budnik N.V., Volkov A.A., Dukhin A.R. Lower urinary tract symptoms and erectile dysfunction assessment, as quality of life baseline in patients with BPH, before medical treatment. Dal’nevostochny meditsinsky zhurnal = Far East Medical Journal 2012;(1):51—5. (In Russ.).

4. Tyuzikov I.A., Kalinchenko S.Yu. Benign prostatic hyperplasia as a systemic hormone-metabolic disease: time to change paradigm of pathogenesis and drug therapy. Effektivnaya farmako-terapiya = Effective Pharmacotherapy 2016;(33):32—53. (In Russ.).

5. Marberger M., Harkaway R., de la Rosette J. Optimising the medical management of benign prostatic hyperplasia. Eur Urol 2004;45(4):411—9. DOI: 10.1016/j.eururo.2003.10.016. PMID: 15041103.